S100B Protein Detection in Serum Is a Significant Prognostic Factor in Metastatic Melanoma

Publisher： Karger

E-ISSN： 1423-0232|56|4|338-344

ISSN： 0030-2414

Source： Oncology, Vol.56, Iss.4, 1999-05, pp. : 338-344

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Survival Analysis in Metastatic Melanoma: Serum S100B Is an Independent Prognostic Marker and Superior to LDH

By  

Oncology Research and Treatment, Vol. 31, Iss. 7, 2008-06 ,pp. : 380-384

Karger

Access to resources Recommend Favorite

Heterogenous S-100B Protein Expression Patterns in Malignant Melanoma and Association with Serum Protein Levels

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 374-379

Karger

Access to resources Recommend Favorite

Serum S100B Levels Correlate with Clinical Benefit in a Metastatic Melanoma Patient Treated by CTLA-4 Blockade: A Case Report

By  

Oncology Research and Treatment, Vol. 36, Iss. 10, 2013-09 ,pp. : 578-581

Karger

Access to resources Recommend Favorite

The Prognostic Significance of c-erbB-2 Serum Protein in Metastatic Breast Cancer

By  

Oncology, Vol. 55, Iss. 1, 1997-12 ,pp. : 33-38

Karger

Access to resources Recommend Favorite

Serum Protein S-100 Predicts Clinical Outcome in Patients with Melanoma Treated with Adjuvant Interferon – Comparison with Tyrosinase RT-PCR

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 341-349

Karger

Access to resources Recommend Favorite